ConductScience.org, home

Trial · NCT03932799

Outcomes18

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYSubacute Phase - More Than 7 Days of Opioids6-12 weeks after injury% of participantsNUMBER
PRIMARYChronic Phase - Composite (Meeting ≥1 of the 3 Chronic Phase Metrics)3-6, 6-9, and 9-12 months after injury% of participantsNUMBER
PRIMARYChronic Phase - Chronic Opioids (≥60 Days' Supply)3-6, 6-9, and 9-12 months after injury% of participantsNUMBER
PRIMARYChronic Phase - Concurrent (Concurrent Sedatives/Hypnotics and Opioids on ≥1 Day)3-6, 6-9, and 9-12 months% of participantsNUMBER
PRIMARYChronic Phase - High Dose (Average of ≥50 Morphine Equivalent Daily Dose [MEDD] Among All Days With Opioids)3-6, 6-9, and 9-12 months after injury% of participantsNUMBER
SECONDARY≥30% Decrease in Pain Intensity/Interference (PEG-3)12 months after injury* Analysis performed within a distinct survey sample of workers~* Estimates for Washington (WA) have been survey-weighted; sampling weights for Ohio (OH) were always 1.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYAnxious Symptoms (PHQ-4)12 months after injury* Analysis performed within a distinct survey sample of workers~* Estimates for WA have been survey-weighted; sampling weights for OH were always 1.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYDepressive Symptoms (PHQ-4)12 months after injury* Analysis performed within a distinct survey sample of workers~* Estimates for WA have been survey-weighted; sampling weights for OH were always 1.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYGlobal Improvement (GIC)12 months after injury* Analysis performed within a distinct survey sample of workers~* Estimates for WA have been survey-weighted; sampling weights for OH were always 1.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYDisability - Activity Limitation12 months after injury* Analysis performed within a distinct survey sample of workers~* Estimates for WA have been survey-weighted; sampling weights for OH were always 1.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNot Working for Pay12 months after injury* Analysis performed within a distinct survey sample of workers~* Estimates for WA have been survey-weighted; sampling weights for OH were always 1.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYOn Time Loss (Not Working)12 months after injury* Analysis performed within a distinct survey sample of workers~* Estimates for WA have been survey-weighted; sampling weights for OH were always 1.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYEarning Less Than Before Injury12 months after injury* Analysis performed within a distinct survey sample of workers~* Estimates for WA have been survey-weighted; sampling weights for OH were always 1.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYOpioid Overdose/Adverse Effects12 months after injury* Analysis performed within a distinct survey sample of workers~* Estimates for WA have been survey-weighted; sampling weights for OH were always 1.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYQuality of Life (EuroQol EQ-5D)12 months after injury* Analysis performed within a distinct survey sample of workers~* Estimates for WA have been survey-weighted; sampling weights for OH were always 1.index valueMEAN
SECONDARYSatisfaction With Overall Treatment12 months after injury* Analysis performed within a distinct survey sample of workers~* Estimates for WA have been survey-weighted; sampling weights for OH were always 1.score on 5-point Likert scaleMEAN
SECONDARYSatisfaction With Pain-related Treatment12 months after injury* Analysis performed within a distinct survey sample of workers~* Estimates for WA have been survey-weighted; sampling weights for OH were always 1.score on 5-point Likert scaleMEAN
OTHER_PRE_SPECIFIEDProblematic Opioid Use (TAPS)12 months after injury* Analysis performed within a distinct survey sample of workers~* Estimates for WA have been survey-weighted; sampling weights for OH were always 1.ParticipantsCOUNT_OF_PARTICIPANTS

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03932799/outcomes